Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)

RecruitingOBSERVATIONAL

Enrollment

104

Participants

Timeline

Start Date

January 11, 2018

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Diabetic Retinopathy

Interventions

BIOLOGICAL

blood draw

Blood sample will be obtained and CD34+ cells will be isolated for functional testing.

Trial Locations (1)

RECRUITING

University of Alabama at Birmingham, Birmingham

All Listed Sponsors

lead

University of Alabama at Birmingham

OTHER